Hyperliquid Strategies, Inc. (PURR)
8.78
+0.10
(+1.15%)
USD |
NASDAQ |
Oct 23, 16:00
8.80
+0.02
(+0.23%)
After-Hours: 20:00
Hyperliquid Strategies Enterprise Value : 1.623B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.623B |
| October 22, 2026 | 1.603B |
| October 21, 2026 | 1.791B |
| October 20, 2026 | 1.697B |
| October 19, 2026 | 1.661B |
| October 16, 2026 | 1.681B |
| October 15, 2026 | 1.827B |
| October 14, 2026 | 1.761B |
| October 13, 2026 | 1.914B |
| October 12, 2026 | 1.948B |
| October 09, 2026 | 2.090B |
| October 08, 2026 | 2.128B |
| October 07, 2026 | 2.215B |
| October 06, 2026 | 2.369B |
| October 05, 2026 | 2.453B |
| October 02, 2026 | 2.247B |
| October 01, 2026 | 2.275B |
| September 30, 2026 | 2.323B |
| September 29, 2026 | 2.253B |
| September 28, 2026 | 2.285B |
| September 25, 2026 | 2.439B |
| September 24, 2026 | 2.688B |
| September 23, 2026 | 2.658B |
| September 22, 2026 | 2.660B |
| September 21, 2026 | 2.580B |
| Date | Value |
|---|---|
| September 18, 2026 | 2.688B |
| September 17, 2026 | 2.435B |
| September 16, 2026 | 2.156B |
| September 15, 2026 | 2.108B |
| September 14, 2026 | 2.239B |
| September 11, 2026 | 2.190B |
| September 10, 2026 | 2.070B |
| September 09, 2026 | 2.275B |
| September 08, 2026 | 2.255B |
| September 04, 2026 | 2.305B |
| September 03, 2026 | 2.423B |
| September 02, 2026 | 2.132B |
| September 01, 2026 | 2.139B |
| August 31, 2026 | 2.319B |
| August 28, 2026 | 2.190B |
| August 27, 2026 | 2.435B |
| August 26, 2026 | 2.180B |
| August 25, 2026 | 2.243B |
| August 24, 2026 | 1.996B |
| August 21, 2026 | 1.984B |
| August 20, 2026 | 1.884B |
| August 19, 2026 | 1.745B |
| August 18, 2026 | 1.306B |
| August 17, 2026 | 1.296B |
| August 14, 2026 | 1.202B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Strive, Inc. (United States) | 2.891B |
| Meridian Holdings, Inc. (California) | 4.053M |
| ACADIA Pharmaceuticals, Inc. | 2.514B |
| Agenus, Inc. | 534.42M |
| Alnylam Pharmaceuticals, Inc. | 29.64B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 470.89M |
| Revenue (Quarterly) | 6.334M |
| Total Expenses (Quarterly) | -464.56M |
| EPS Diluted (Quarterly) | 2.102 |
| Earnings Yield | 7.40% |
| Normalized Earnings Yield | -21.10 |